Related Experiment Videos
Alternative processing of RNA transcribed from NMYC
1Department of Microbiology and Immunology, University of California Medical Center, San Francisco 94143.
Abstract:
NMYC is a gene whose amplification and overexpression have been implicated in the generation of certain human malignancies. Little is known of how the expression of NMYC is normally controlled. We have therefore characterized transcription from the gene and the structure and stability of the resulting mRNAs. Transcription from NMYC is exceptionally complex: it initiates at numerous sites that may be grouped under the control of two promoters, and the multiplicity of initiation sites combines with alternative splicing to engender two forms of mRNA. The mRNAs have different 5' leader sequences (alternative first exons of the gene) but identical bodies (the second and third exons of the gene). Both forms of mRNA are unstable, with half-lives of ca. 15 min. Both encode the previously identified 65,000 and 67,000-dalton products of NMYC. However, the alternative first exons contain distinctive open reading frames that may diversify the coding potential of NMYC. The complexities in transcription of NMYC expand the means by which expression of the gene might be controlled.
Insights
The NMYC gene
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- NMYC amplification and overexpression are linked to human cancers.
- Understanding NMYC gene expression control is crucial but limited.
- NMYC plays a role in oncogenesis.
Purpose of the Study:
- Characterize NMYC gene transcription.
- Analyze the structure and stability of NMYC messenger RNAs (mRNAs).
- Investigate the regulatory mechanisms of NMYC expression.
Main Methods:
- Detailed analysis of NMYC gene transcription initiation.
- Investigation of alternative splicing events in NMYC mRNA.
- Assessment of NMYC mRNA stability and half-life.
- Identification of NMYC protein products.
Main Results:
- NMYC transcription initiates at multiple sites under two promoters.
- Alternative splicing generates two NMYC mRNA forms with distinct 5' leaders.
- Both mRNA forms are unstable with short half-lives (approx. 15 minutes).
- Alternative first exons contain unique open reading frames, potentially diversifying NMYC coding potential.
Conclusions:
- NMYC gene expression is regulated by complex transcription and alternative splicing.
- The identified mRNA variants and their coding potential offer new regulatory possibilities.
- These findings expand our understanding of NMYC gene regulation in normal and malignant cells.